HIT Consultant August 5, 2024
What You Should Know:
– venBio, a leading life sciences venture capital firm, announced the successful closing of its fifth fund, venBio Fund V, with over $528M in capital commitments.
– The new fund will focus on investing in biopharmaceutical companies developing innovative treatments for unmet medical needs.
venBio Fund V Focus
With a strong track record of successful investments in companies such as Labrys...